Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04575233Completed
Randomised, open-label trial of ropivacaine in postoperative pain. Primary endpoint: Opioid consumption at 24 hours. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04575233.